505 related articles for article (PubMed ID: 19736626)
1. Future potential and status of selective sodium channel blockers for the treatment of pain.
Priest BT
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.
Williams BS; Felix JP; Priest BT; Brochu RM; Dai K; Hoyt SB; London C; Tang YS; Duffy JL; Parsons WH; Kaczorowski GJ; Garcia ML
Biochemistry; 2007 Dec; 46(50):14693-703. PubMed ID: 18027973
[TBL] [Abstract][Full Text] [Related]
3. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in the structure-activity relationship study of small-molecule sodium channel blockers with analgesic effects].
Li W; Zhou Y; Liu HM; You QD
Yao Xue Xue Bao; 2009 Feb; 44(2):101-8. PubMed ID: 19408676
[TBL] [Abstract][Full Text] [Related]
5. Voltage-gated sodium channels and pain pathways.
Wood JN; Boorman JP; Okuse K; Baker MD
J Neurobiol; 2004 Oct; 61(1):55-71. PubMed ID: 15362153
[TBL] [Abstract][Full Text] [Related]
6. Sodium channels and nociception: recent concepts and therapeutic opportunities.
Krafte DS; Bannon AW
Curr Opin Pharmacol; 2008 Feb; 8(1):50-6. PubMed ID: 17964852
[TBL] [Abstract][Full Text] [Related]
7. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats.
Lindia JA; Köhler MG; Martin WJ; Abbadie C
Pain; 2005 Sep; 117(1-2):145-53. PubMed ID: 16061326
[TBL] [Abstract][Full Text] [Related]
8. Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain.
Gaida W; Klinder K; Arndt K; Weiser T
Neuropharmacology; 2005 Dec; 49(8):1220-7. PubMed ID: 16182323
[TBL] [Abstract][Full Text] [Related]
9. Isoform-selective voltage-gated Na(+) channel modulators as next-generation analgesics.
England S; Rawson D
Future Med Chem; 2010 May; 2(5):775-90. PubMed ID: 21426202
[TBL] [Abstract][Full Text] [Related]
10. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
[TBL] [Abstract][Full Text] [Related]
11. Sodium channel blockers for neuropathic pain.
Zuliani V; Rivara M; Fantini M; Costantino G
Expert Opin Ther Pat; 2010 Jun; 20(6):755-79. PubMed ID: 20384535
[TBL] [Abstract][Full Text] [Related]
12. Targeting voltage-gated sodium channels for pain therapy.
Clare JJ
Expert Opin Investig Drugs; 2010 Jan; 19(1):45-62. PubMed ID: 20001554
[TBL] [Abstract][Full Text] [Related]
13. Small molecules targeting sodium and calcium channels for neuropathic pain.
Bear B; Asgian J; Termin A; Zimmermann N
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):543-61. PubMed ID: 19562650
[TBL] [Abstract][Full Text] [Related]
14. Imidazopyridines: a novel class of hNav1.7 channel blockers.
London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
[TBL] [Abstract][Full Text] [Related]
15. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels.
Zhou X; Dong XW; Crona J; Maguire M; Priestley T
J Pharmacol Exp Ther; 2003 Aug; 306(2):498-504. PubMed ID: 12730276
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells.
Dekker LV; Daniels Z; Hick C; Elsegood K; Bowden S; Szestak T; Burley JR; Southan A; Cronk D; James IF
Eur J Pharmacol; 2005 Dec; 528(1-3):52-8. PubMed ID: 16325806
[TBL] [Abstract][Full Text] [Related]
17. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants.
Dick IE; Brochu RM; Purohit Y; Kaczorowski GJ; Martin WJ; Priest BT
J Pain; 2007 Apr; 8(4):315-24. PubMed ID: 17175203
[TBL] [Abstract][Full Text] [Related]
18. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23.
John VH; Main MJ; Powell AJ; Gladwell ZM; Hick C; Sidhu HS; Clare JJ; Tate S; Trezise DJ
Neuropharmacology; 2004 Mar; 46(3):425-38. PubMed ID: 14975698
[TBL] [Abstract][Full Text] [Related]
19. The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs?
Silos-Santiago I
Curr Opin Investig Drugs; 2008 Jan; 9(1):83-9. PubMed ID: 18183535
[TBL] [Abstract][Full Text] [Related]
20. Painful research: identification of a small-molecule inhibitor that selectively targets Nav1.8 sodium channels.
Rush AM; Cummins TR
Mol Interv; 2007 Aug; 7(4):192-5, 180. PubMed ID: 17827438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
